by Eric Christianson | Dec 31, 2025 | Psychiatry and Addiction Medication and Disease State Clinical Pearls
Pimavanserin is a unique antipsychotic with a very specific niche in clinical practice. It is most commonly used for Parkinson’s disease psychosis, and its pharmacology, benefits, and risks are frequently tested and clinically misunderstood. In this blog post,...
by Eric Christianson | Dec 28, 2025 | Renal, Urology, and Electrolytes Medication and Disease State Clinical Pearls
Alpha-blockers are not first-line agents for many conditions, but they are often tested on exams and highly relevant in practice—especially in urology, hypertension, and acute care settings. Understanding their nuances can help prevent serious adverse effects and...
by Eric Christianson | Dec 21, 2025 | Endocrine Case Studies
In this case scenario, we outline a situation where biotin causes thyroid problems. It highlights the importance of recognizing the use of OTC and supplement medications. A 46-year-old woman with a history of primary hypothyroidism presents to her primary care clinic...
by Eric Christianson | Dec 17, 2025 | Women’s and Men’s Health Medication and Disease State Clinical Pearls
As I’m sure many of us who commonly work with elderly patients in nursing homes have seen, patients can experience hypersexuality and exhibit behaviors that put themselves and other residents at risk as a result. Hypersexuality is defined by exhibiting behaviors and...
by Eric Christianson | Dec 14, 2025 | BCMTMS Exam
Are you preparing to take the BCMTMS exam in 2026? Whether you’re a practicing pharmacist considering advanced credentials or a pharmacy student planning ahead, this post breaks down what the BCMTMS exam is, why it matters, key dates for 2026, how to prepare...
